These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 21351716)

  • 1. Is there a cost associated with higher quality?
    Cleverley WO; Cleverley JO
    Healthc Financ Manage; 2011 Jan; 65(1):96-102. PubMed ID: 21351716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical redesign using all patient refined diagnosis related groups.
    Sedman AB; Bahl V; Bunting E; Bandy K; Jones S; Nasr SZ; Schulz K; Campbell DA
    Pediatrics; 2004 Oct; 114(4):965-9. PubMed ID: 15466092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2007 rates; fiscal year 2007 occupational mix adjustment to wage index; health care infrastructure improvement program; selection criteria of loan program for qualifying hospitals engaged in cancer-related health care and forgiveness of indebtedness; and exclusion of vendor purchases made under the competitive acquisition program (CAP) for outpatient drugs and biologicals under part B for the purpose of calculating the average sales price (ASP). Final rules and interim final rule with comment period.
    Centers for Medicare and Medicaid Services (CMS), HHS
    Fed Regist; 2006 Aug; 71(160):47869-8351. PubMed ID: 16921666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and performance of different DRG classification systems for neonatal medicine.
    Muldoon JH
    Pediatrics; 1999 Jan; 103(1 Suppl E):302-18. PubMed ID: 9917473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selecting financial indices to measure critical path outcomes.
    Shikiar MS; Warner P
    Nurs Manage; 1994 Sep; 25(9):58-60. PubMed ID: 8075955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Who pays for poor surgical quality? Building a business case for quality improvement.
    Dimick JB; Weeks WB; Karia RJ; Das S; Campbell DA
    J Am Coll Surg; 2006 Jun; 202(6):933-7. PubMed ID: 16735208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are national DRG rates the best choice for PPS?
    Averill RF; Kalison MJ
    Healthc Financ Manage; 1985 Aug; 39(8):62-6. PubMed ID: 10311204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do older Medicare patients cost hospitals more? Evidence from an academic medical center.
    Rosenthal GE; Landefeld CS
    Arch Intern Med; 1993 Jan; 153(1):89-96. PubMed ID: 8422203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using QA monitors for DRG management.
    Bartek W
    Tex Hosp; 1984 May; 39(12):10. PubMed ID: 10310633
    [No Abstract]   [Full Text] [Related]  

  • 10. Measuring the effect of illness severity on revenue under DRGs.
    Brewster AC; Bradbury RC; Jacobs CM
    Healthc Financ Manage; 1985 Jul; 39(7):52-3, 56-60. PubMed ID: 10311153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of nationwide pharmacy charges per DRG.
    Curtiss FR
    Am J Hosp Pharm; 1985 Oct; 42(10):2168-74. PubMed ID: 3933336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obtaining estimates of marginal cost by DRG.
    Bridges JM; Jacobs P
    Healthc Financ Manage; 1986 Oct; 40(10):40-6. PubMed ID: 10311667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DRGs: the counterrevolution in financing health care.
    Dolenc DA; Dougherty CJ
    Hastings Cent Rep; 1985 Jun; 15(3):19-29. PubMed ID: 3926717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dynamic of the outpatient prospective payment system within the hospital setting.
    Thevnin C
    J Health Care Finance; 2000; 27(2):45-50. PubMed ID: 11140549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Financial management and DRGs.
    Suver JD; Jessee WF; Zelman WN
    Hosp Health Serv Adm; 1986; 31(1):75-85. PubMed ID: 10311404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DRG winners and losers affect profits under prospective payment.
    Mendenhall S
    Healthc Financ Manage; 1985 Jul; 39(7):62-8. PubMed ID: 10311154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Institutional responses to prospective payment based on diagnosis-related groups. Implications for cost, quality, and access.
    Stern RS; Epstein AM
    N Engl J Med; 1985 Mar; 312(10):621-7. PubMed ID: 3919294
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of a clinical knowledge support system with improved patient safety, reduced complications and shorter length of stay among Medicare beneficiaries in acute care hospitals in the United States.
    Bonis PA; Pickens GT; Rind DM; Foster DA
    Int J Med Inform; 2008 Nov; 77(11):745-53. PubMed ID: 18565788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The economic impact of aspergillosis: analysis of hospital expenditures across patient subgroups.
    Tong KB; Lau CJ; Murtagh K; Layton AJ; Seifeldin R
    Int J Infect Dis; 2009 Jan; 13(1):24-36. PubMed ID: 18621562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost and quality: two sides of the coin in cost containment.
    Clifford LA; Plomann MP
    Healthc Financ Manage; 1985 Sep; 39(9):30-2. PubMed ID: 10311240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.